Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0002012383-26-000632·Adaptive Biotechnologies Corp
Schedule 13G ownership disclosure
ADAPTIVE BIOTECHNOLOGIES CORP
Common Stock · CUSIP: 00650F109
Event date: 2025-12-31
- Filing-level shares
- 11,992,448
- Percent of class
- 7.9%
- BlackRock, Inc.
Shares: 11,992,448 · Class: 7.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002012383-26-000632
- Form type
- SCHEDULE 13G/A
- Filer
- Adaptive Biotechnologies Corp
- CIK
- CIK 1478320
- Filed
- Jan 21, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership